Does Radioactive Iodine Treatment Damage the Lacrimal System?

• Published in: Clinical nuclear medicine 2024-06, Vol.49 (6), p.513-515
• Main Authors: Gürez, Ceren, Ergül, Nurhan
• Format: Article
• Language: English
• Subjects: Adult; Aged; Female; Humans; Hyperthyroidism - radiotherapy; Iodine Radioisotopes - adverse effects; Lacrimal Apparatus; Male; Middle Aged; Tears; Thyroid Neoplasms - radiotherapy
• ISSN: 0363-9762; 1536-0229
• DOI: 10.1097/RLU.0000000000005147

In this prospective study, we aimed to make a quantitative assessment of the lacrimal glands before and after radioactive iodine (RAI) treatment in patients with hyperthyroidism and thyroid cancer. The study included 80 eyes of 40 patients. There were 25 patients in group 1 (hyperthyroid group) and 15 patients in group 2 (thyroid cancer group). Group 1 has received low dose ( 131 I) and group 2 high dose ( 131 I). Before, and at the first and sixth month after RAI treatment, all patients underwent ophthalmological examinations, Schirmer tests, TBUT tests, tear osmolarity (TO), and ocular surface examinations. The age and sex characteristics of both groups were similar. Although no significant change was observed in tear film tests before and after treatment in group 1, a significant decrease in Schirmer and TBUT values and a significant increase in TO were observed in group 2 in the first month after treatment. These values returned to normal in the sixth month. Although no Schirmer test was observed lower than 10 mm in any patient before RAI treatment, the Schirmer test was measured 5 to 10 mm in 4 (10%) patients in group 2 in the first month after treatment. Again, in these patients, TBUT was below 10 seconds and TO was greater than 308 mOsm/L. In this study, although no change was observed in tear function tests in patients receiving low doses of RAI, a decrease in tear secretion and an increase in TO were detected in patients receiving high doses in the early period.